Last Updated : October 17, 2014
Details
FilesGeneric Name:
Aflibercept
Project Status:
Complete
Therapeutic Area:
Macular edema, central retinal vein occlusion
Manufacturer:
Bayer Inc.
Call for patient/clinician input open:
Brand Name:
Eylea
Project Line:
Reimbursement Review
Project Number:
SR0401-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Macular edema secondary to central retinal vein occlusion
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : October 17, 2014